Treating the primary in low burden metastatic prostate cancer: Where do we stand?

On the basis of endocrine therapy for patients with low burden metastatic prostate cancer (LBMP), the clinical efficacy and quality of life were compared between prostate-only directed radiotherapy (PODT) and prostate and metastasis radiotherapy (PMRT). From November 2009 to November 2015, total 91...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Hua-Chun, Fu, Zhi-Chao, Wang, Xin-Peng, Cai, Lv-Juan, Wang, Feng-Mei, Yin, Qin, Lin, Guishan, Chen, Zhong-Hua, Liao, Shao-Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748322/
https://www.ncbi.nlm.nih.gov/pubmed/33371121
http://dx.doi.org/10.1097/MD.0000000000023715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748322/
https://www.ncbi.nlm.nih.gov/pubmed/33371121
http://dx.doi.org/10.1097/MD.0000000000023715

Ejemplares similares